SPHERA BIOTECH MASTER
SPHERA BIOTECH MASTER
Status:
Active
Similar Organizations
AK Partners
AK Partners is an investment firm.
Ashe Partners
Ashe Partners is an investment firm.
Aternus
Aternus is an investment firm.
Belief Partners
Belief Partners is an investment firm.
Bie Partners
Bie Partners is an investment firm.
DCH partner
DCH partner is an investment firm.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-07-25 | Chemomab | Sphera Biotech Master investment in Post-IPO Equity - Chemomab | 10 M USD |
More informations about "Sphera Biotech Master"
Sphera Biotech Master - Crunchbase Investor Profile & Investments
Sphera Biotech Master is an investment firm. Lists Featuring This Company. Edit Lists Featuring This Company Section. ... 2,609 Number of Organizations โข $360.8B Total Funding Amount โข โฆSee details»
Chemomab Therapeutics Announces Closing of $10 Million Private โฆ
Jul 30, 2024 โ HBM Healthcare Investments, OrbiMed and Sphera Biotech Master Fund LP Participated in the Financing that Extends Cash Runway Potentially to the Beginning of โฆSee details»
ืงืจื ืกืคืจื Sphera Strategy
With a focus on investments in the global pharmaceutical and biotechnology sectors, this long/short equity strategy was founded in 2007. Sphera Global Healthcareโs investments are โฆSee details»
Chemomab Therapeutics Announces Closing of $10 Million Private โฆ
Jul 30, 2024 Chemomab Therapeutics โ HBM Healthcare Investments, OrbiMed and Sphera Biotech Master Fund LP Participated in the Financing that Extends Cash Runway Potentially โฆSee details»
Chemomab Therapeutics Announces $10 Million Private Placement
Jul 25, 2024 The PIPE included participation from both new investors, including HBM Healthcare Investments and Sphera Biotech Master Fund LP, and existing investors. Chemomab expects โฆSee details»
Chemomab Therapeutics Announces Closing of $10 Million Private ...
Jul 30, 2024 โ HBM Healthcare Investments, OrbiMed and Sphera Biotech Master Fund LP Participated in the Financing that Extends Cash Runway Potentially to the Beginning ofSee details»
Chemomab Therapeutics Announces $10 Million Private
Jul 25, 2024 The PIPE included participation from both new investors, including HBM Healthcare Investments and Sphera Biotech Master Fund LP, and existing investors. Chemomab expects โฆSee details»
Sphera Biotech Master Fund LP - AUM 13F
Fund Details; Director: Sphera Biotech GP LP: Custodian: Jefferies LLC, Northern Trust International Banking Corporation, JP Morgan Securities PLC, Morgan Stanley & Co โฆSee details»
Sphera Biotech Master โ Investments, Portfolio, Team members โฆ
Sphera Biotech Master. Search. Overview Investments Unlock datapoints. Portfolio analytics Team News & Media. Add fund to favorites. Save this fund for later to form your own custom โฆSee details»
Sphera Biotech Master Fund L.P. · c/o Sphera Funds Management, โฆ
Sphera Biotech Master Fund L.P. (LEI# 254900TC77SMC63PWW83) is a legal entity registered with Bloomberg Finance L.P.. The address is c/o Sphera Funds Management, P.O. Box 309, โฆSee details»
SEC.gov
CITIZENSHIP OR PLACE OF ORGANIZATION ... 6,040,243 Common Shares representing a total of 5.41% of the total Common Shares outstanding, are held directly by Sphera Biotech โฆSee details»
Chemomab Therapeutics Announces Closing of $10 Million Private ...
Jul 30, 2024 About Chemomab Therapeutics Ltd. Chemomab is a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet โฆSee details»
LABOMAR ACQUIRES A STAKE OF SPHERA ENCAPSULATION
Jul 9, 2024 Labomar has acquired a stake of Sphera, which was founded in 2016 as a spin-off of the Department of Biotechnology of the University of Verona. The company operates in the โฆSee details»
Chemomab Therapeutics Announces Closing of $10 Million
Jul 30, 2024 โ HBM Healthcare Investments, OrbiMed and Sphera Biotech Master Fund LP Participated in the Financing that Extends Cash Runway Potentially to the Beginning of โฆSee details»
SECURITIES AND EXCHANGE COMMISSION - SEC.gov
Sep 22, 2023 Incorporation or Organization) ... Sphera Biotech Master Fund, L.P., which includes 2,129,229 Common Warrant Shares and 295,187 Pre-Funded Warrant Shares. The โฆSee details»
Chemomab Therapeutics Announces Closing of $10 Million Private ...
Jul 30, 2024 Chemomab Therapeutics (Nasdaq: CMMB) has successfully closed a $10 million private placement, extending its cash runway potentially to early 2026.The financing, which โฆSee details»
tm249132-1_s3 - none - 5.3750087s - SEC.gov
Mar 22, 2024 Sphera Global Healthcare Management LP is the general partner of the Sphera General Partner and acts as the Investment Manager for Sphera Biotech Master Fund and โฆSee details»
Sphera - Leadership Team - The Org
The Leadership Team at Sphera is responsible for setting the strategic direction and vision of the company, driving innovation in Environmental, Social, and Governance (ESG) performance, โฆSee details»
Our Leadership - Sphera
Spheraโs industryโleading ORM solution drives operational excellence. Organizations improve safety, mitigate risk, reduce costs and build resilience. ... Master Data Management; Advanced โฆSee details»
Breakthrough data using Q-Sphera technology
Midatech Pharma PLC (AIM: MTPH.L; Nasdaq: MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, announces breakthrough in โฆSee details»